Kobe University Repository : Kernel タイトル Tit le CD 244 + polymorphonuclear myeloid ‐ derived suppressor cells reflect the status of peritoneal disseminat ion in a colon cancer mouse model 著者
暂无分享,去创建一个
Y. Kakeji | T. Oshikiri | H. Hasegawa | S. Kanaji | K. Yamashita | T. Matsuda | Tetsuo Nakamura | Satoshi Suzuki | M. Fujita | Kota Yamada | Akihiro Watanabe | Kyosuke Agawa | Masafumi Saito | Eiji Fukuoka | Yutaka Sugita
[1] D. Gabrilovich,et al. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.
[2] Ihor O. Arkhypov,et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. , 2020, Cellular immunology.
[3] Yu Seong Lee,et al. Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer , 2020, Journal for ImmunoTherapy of Cancer.
[4] S. Abrams,et al. Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity , 2020, Frontiers in Immunology.
[5] K. Hoebe,et al. CD244 represents a new therapeutic target in head and neck squamous cell carcinoma , 2020, Journal for ImmunoTherapy of Cancer.
[6] O. De Wever,et al. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases. , 2020, Trends in cancer.
[7] D. Gallego-Ortega,et al. Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer , 2020, Cells.
[8] H. Rugo,et al. NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] J. Pouysségur,et al. Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response , 2019, International journal of molecular sciences.
[10] A. Kotsakis,et al. Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer , 2019, Cells.
[11] C. Yardin,et al. Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging , 2019, PloS one.
[12] J. Schlom,et al. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. , 2019, JCI insight.
[13] M. Kurachi. CD8+ T cell exhaustion , 2019, Seminars in Immunopathology.
[14] M. Masařík,et al. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review , 2019, Molecular Cancer.
[15] E. Moon,et al. CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment , 2019, Front. Immunol..
[16] J. Pollard,et al. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates , 2019, Cancer Immunology, Immunotherapy.
[17] K. Hoebe,et al. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment , 2018, Front. Immunol..
[18] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[19] Sean C. Bendall,et al. A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging , 2018, Cell.
[20] G. Lyman,et al. Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] Y. Kakeji,et al. Immunosuppression Induced by Perioperative Peritonitis Promotes Lung Metastasis , 2018, AntiCancer Research.
[22] D. Valík,et al. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment , 2018, Cancer Immunology, Immunotherapy.
[23] R. Weinberg,et al. Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.
[24] Z. Fan,et al. Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[25] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.
[26] Xiaomin Su,et al. LncRNA RNCR3 promotes Chop expression by sponging miR-185-5p during MDSC differentiation , 2017, Oncotarget.
[27] Laurence Zitvogel,et al. The immune contexture in cancer prognosis and treatment , 2017, Nature Reviews Clinical Oncology.
[28] Y. Kakeji,et al. Frequency of Myeloid-derived Suppressor Cells in the Peripheral Blood Reflects the Status of Tumor Recurrence. , 2017, Anticancer research.
[29] F. Pedeutour,et al. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes. , 2017, American journal of surgery.
[30] C. Tournigand,et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. , 2016, The Lancet. Oncology.
[31] K. E. Visser,et al. Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.
[32] A. Biankin,et al. CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma , 2016, Cancer cell.
[33] M. Gunzer,et al. Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody‐mediated depletion of Ly‐6G+ cells in tumor‐bearing mice , 2016, Journal of leukocyte biology.
[34] D. Mougiakakos,et al. TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection. , 2016, Cell reports.
[35] E. Morii,et al. The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer , 2015, Scientific Reports.
[36] Y. Kakeji,et al. Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation. , 2015, Anticancer research.
[37] E. Wherry,et al. Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.
[38] P. Sugarbaker. Colorectal Cancer: Prevention and Management of Metastatic Disease , 2014, BioMed research international.
[39] I. Pinchuk,et al. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration , 2014, British Journal of Cancer.
[40] Ada T Feldman,et al. Tissue processing and hematoxylin and eosin staining. , 2014, Methods in molecular biology.
[41] W. Pan,et al. Monocyte/macrophage‐elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions , 2013, Hepatology.
[42] Xiaopei Huang,et al. NK Cell Response to Vaccinia Virus Is Regulated by Myeloid-Derived Suppressor Cells , 2012, The Journal of Immunology.
[43] R. Bleichrodt,et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[44] F. Granath,et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer , 2012, The British journal of surgery.
[45] I. Cuthill,et al. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research † , 2012, Osteoarthritis and cartilage.
[46] D. Gabrilovich,et al. Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.
[47] S. Biswas,et al. Characterization of the nature of granulocytic myeloid‐derived suppressor cells in tumor‐bearing mice , 2012, Journal of leukocyte biology.
[48] Qiang Hu,et al. Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism , 2011, PloS one.
[49] D. Gabrilovich,et al. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.
[50] K. Sugamura,et al. Generation of a syngeneic mouse model to study the intraperitoneal dissemination of ovarian cancer with in vivo luciferase imaging. , 2009, Luminescence : the journal of biological and chemical luminescence.
[51] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[52] H. Yamaue,et al. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)‐expressing colon cancer using genetically modified dendritic cells that express CEA and T helper‐type 1 cytokines in CEA transgenic mice , 2007, International journal of cancer.
[53] N. Kearney,et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. , 2006, European journal of cancer.
[54] J. Simpson,et al. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. , 1998, Cancer research.